$JHIUF

James Hardie Industries plc

CIK:0001159152|SEC Filings

Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Income Statement [Abstract]
Net sales	$ 1,474.6	$ 899.9
Cost of goods sold	925.9	563.0
Gross profit	548.7	336.9
Selling, general and administrative expenses	295.4	156.1
Research and development expenses	15.4	12.1
Restructuring expenses	5.2	0.0
Acquisition related expenses	16.6	29.4
Asbestos adjustments	(1.6)	0.7
Operating income	217.7	138.6
Interest, net	61.5	37.8
Other (income) expense, net	(1.1)	11.1
Income before income taxes	157.3	89.7
Income tax expense	53.0	27.1
Net income	$ 104.3	$ 62.6
Income per share:
Basic (in dollars per share)	$ 0.18	$ 0.15
Diluted (in dollars per share)	$ 0.18	$ 0.15
Weighted average common shares outstanding (Millions):
Basic (in shares)	580.3	429.9
Diluted (in shares)	584.3	431.1
Comprehensive income, net of tax:
Net income	$ 104.3	$ 62.6
Currency translation adjustments	(8.6)	24.3
Cash flow hedges	5.3	0.0
Comprehensive income	$ 101.0	$ 86.9

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash Flows from Operating Activities
Net income	$ 104.3	$ 62.6
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	168.8	56.5
Lease expense	12.5	8.3
Deferred income taxes	29.0	13.8
Share-based compensation	12.0	6.9
Asbestos adjustments	(1.6)	0.7
Non-cash restructuring expenses	1.7	0.0
Non-cash interest expense	2.9	33.6
Other, net	7.3	22.1
Changes in operating assets and liabilities:
Accounts and other receivables	56.0	77.7
Inventories	26.0	(26.8)
Operating lease assets and liabilities, net	(14.3)	(7.9)
Prepaid expenses and other assets	(20.6)	(16.9)
Insurance receivable — Asbestos	0.8	0.9
Accounts payable and accrued liabilities	(10.8)	33.3
Claims and handling costs paid — Asbestos	(33.1)	(29.3)
Income taxes payable	13.6	4.6
Other accrued liabilities and interest	(10.5)	(33.2)
Net cash provided by operating activities	344.0	206.9
Cash Flows from Investing Activities
Purchases of property, plant and equipment	(89.8)	(103.2)
Capitalized interest	0.0	(2.1)
Purchase of restricted investments — Asbestos	(76.1)	(56.6)
Proceeds from restricted investments — Asbestos	62.3	56.6
Net cash used in investing activities	(103.6)	(105.3)
Cash Flows from Financing Activities
Proceeds from senior secured notes	0.0	1,700.0
Proceeds from revolving facility	530.0	0.0
Repayments of term loans	(10.9)	(290.6)
Repayments of revolving facility	(380.0)	0.0
Repayment of senior unsecured notes	(400.0)	0.0
Debt issuance costs paid	0.0	(6.3)
Proceeds from exercise of vested stock options	1.0	0.0
Repayment of finance lease obligations	(1.4)	(0.3)
Cash paid for shares withheld for taxes	(0.1)	0.0
Net cash (used in) provided by financing activities	(261.4)	1,402.8
Effects of exchange rate changes on cash and cash equivalents, restricted cash and restricted cash — Asbestos	(1.4)	1.8
Net (decrease) increase in cash and cash equivalents, restricted cash and restricted cash — Asbestos	(22.4)	1,506.2
Cash and cash equivalents, restricted cash and restricted cash — Asbestos at beginning of period	344.4	605.6
Cash and cash equivalents, restricted cash and restricted cash — Asbestos at end of period	322.0	2,111.8
Non-Cash Investing and Financing Activities
Capital expenditures incurred but not yet paid	27.1	19.6
Non-cash ROU assets obtained in exchange for new lease liabilities	9.4	2.7
Supplemental Disclosure of Cash Flow Activities
Cash paid for interest	$ 41.2	$ 4.6

Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Jun. 30, 2026	Mar. 31, 2026
Current assets:
Cash and cash equivalents	$ 289.9	$ 269.2
Restricted cash and cash equivalents	32.1	75.2
Restricted short-term investments — Asbestos	212.9	198.5
Accounts and other receivables, net	499.6	517.3
Inventories	612.1	635.7
Prepaid expenses and other current assets	101.8	120.0
Assets held for sale	10.8	10.9
Total current assets	1,759.2	1,826.8
Property, plant and equipment, net	3,051.4	3,084.6
Operating lease right-of-use assets	130.3	133.4
Finance lease right-of-use assets	97.7	100.8
Goodwill	4,775.8	4,780.4
Intangible assets, net	3,260.5	3,340.1
Deferred income taxes	71.3	73.3
Deferred income taxes — Asbestos	276.3	282.5
Other assets	70.9	66.7
Total assets	13,493.4	13,688.6
Current liabilities:
Accounts payable and accrued liabilities	699.6	712.5
Accrued payroll and employee benefits	124.7	167.9
Operating lease liabilities	33.6	32.9
Finance lease liabilities	6.3	5.6
Long-term debt, current portion	43.8	43.8
Accrued product warranties	11.1	10.7
Income taxes payable	26.5	13.1
Asbestos liability	128.8	128.3
Other liabilities	35.1	42.6
Total current liabilities	1,109.5	1,157.4
Long-term debt	4,232.9	4,491.2
Deferred income taxes	426.3	399.7
Operating lease liabilities	109.5	114.3
Finance lease liabilities	95.9	97.9
Accrued product warranties	53.9	53.3
Asbestos liability	851.4	880.3
Other liabilities	73.4	69.0
Total liabilities	6,952.8	7,263.1
Commitments and contingencies (Note 11)
Shareholders’ equity:
Common stock, Euro 0.59 par value, 2.0 billion shares authorized; 580,354,409 shares issued and outstanding at June 30, 2026 and 580,174,308 shares issued and outstanding at March 31, 2026	326.8	326.7
Additional paid-in capital	4,329.4	4,315.4
Retained earnings	1,934.0	1,829.7
Accumulated other comprehensive loss	(49.6)	(46.3)
Total shareholders’ equity	6,540.6	6,425.5
Total liabilities and shareholders’ equity	$ 13,493.4	$ 13,688.6